Earlier this week, Hindustan Syringes & Medical Devices Ltd (HMD), one of the world’s largest makers of syringes, received an order from the Indian government to supply 265 million auto-disable syringes for the country’s COVID-19 vaccination programme.
Sold under the brand name Kojak Selinge, these auto-disable syringes (AD syringes) are available in different sizes for both mass immunisation programmes (0.1 ml, 0.3 ml, 0.5 ml and 1ml) and general use (2 ml, 3 ml, 5 ml, 10 ml, 20 ml).
(Rajiv Nath, MD of HMD, receiving a jab of Covaxin on the left during the clinical trial, and a representative image.)
This is the fourth order (valued at approximately Rs 55 crore) the government has placed with the syringe-making major. The previous three orders for the 0.5 ml auto-disable syringes totalling to 177.5 million pieces are approaching completion at the end of this month. Supplies for the latest order will continue till September 2021.
“This is in addition to our ongoing global…
